-
公开(公告)号：EP3254695B1
公开(公告)日：2020-09-09
申请号：EP17171169.0
申请日：2013-05-21
申请人： Astellas Pharma Inc. , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人： SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , JACOBS, Stefan, Denis , UTSCH, Magdalena, Jadwiga , HEINZ, Cornelia, Adriana, Maria , STADLER, Christiane, Regina
IPC分类号： A61K39/395 , C07K16/30 , A61K45/06
-
公开(公告)号：EP3791896A1
公开(公告)日：2021-03-17
申请号：EP20194625.8
申请日：2013-05-21
申请人： Astellas Pharma Inc. , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人： SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , JACOBS, Stefan, Denis , UTSCH, Magdalena, Jadwiga , HEINZ, Cornelia, Adriana, Maria , STADLER, Christiane, Regina
IPC分类号： A61K39/395 , C07K16/30 , A61K45/06
摘要： The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
-
3.发明授权COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER 有权克劳丁18.2治疗癌症涉及抗体的联合治疗
公开(公告)号：EP2852408B1
公开(公告)日：2017-05-17
申请号：EP13724523.9
申请日：2013-05-21
申请人： Ganymed Pharmaceuticals AG , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人： SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , JACOBS, Stefan, Denis , UTSCH, Magdalena, Jadwiga , HEINZ, Cornelia, Adriana, Maria , STADLER, Christiane Regina
IPC分类号： A61K39/395 , C07K16/30 , A61K45/06
CPC分类号： A61K39/39558 , A61K45/06 , C07K16/30 , C07K16/3046 , A61K2300/00
-
公开(公告)号：EP3254695A1
公开(公告)日：2017-12-13
申请号：EP17171169.0
申请日：2013-05-21
申请人： GANYMED Pharmaceuticals AG , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
发明人： SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , JACOBS, Stefan, Denis , UTSCH, Magdalena, Jadwiga , HEINZ, Cornelia, Adriana, Maria , STADLER, Christiane, Regina
IPC分类号： A61K39/395 , C07K16/30 , A61K45/06
摘要： The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
-
-
-
搜索结果
4 条记录 (耗时 0.016 秒)
